Enzymatic variability of Candida krusei isolates in a course of fungal infection in a liver transplant recipient

Transplantation Proceedings

Volumn 38, Issue 1, 2006, Pages 250-252

  Kawecki, D ^a   Swoboda Kopec, E ^a   Dabkowska, M ^a   Stelmach, E ^a   Wroblewska, M ^a   Krawczyk, M ^a   Blachnio, S ^a   Luczak, M ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ARYL ACYLAMIDASE; ESTERASE LIPASE; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG; VALINE ARYL ACYLAMIDASE;

BILE; BIOTYPE; CANDIDA KRUSEI; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVITY; FECES; FUNGUS ISOLATION; HUMAN; LIVER TRANSPLANTATION; MYCOSIS; NONHUMAN; NOSE; PERITONEAL CAVITY; PRIORITY JOURNAL; THROAT CULTURE;

CANDIDA; CANDIDIASIS; HUMANS; LIVER TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS;

EID: 33644527276     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2005.11.096     Document Type: Conference Paper

References (21)

1. N. Singh Invasive mycoses in organ transplant recipients controversies in prophylaxis and management J Antimicrob Chemother 45 2000 749
2. M.M. Wroblewska, E. Swoboda-Kopec, A. Rokosz Epidemiology of clinical isolates of Candida albicans and their susceptibility to triazoles Internat J Antimicrob Agents 20 2002 472
3. B.D. Alexander Prophylaxis of invasive mycoses in solid organ transplantation Curr Opin Infect Dis 15 2002 583
4. J.R. Wingard, W.G. Merz, M.G. Rinaldi Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole New Engl J Med 325 1991 1274
5. L.P. Nicod, J.-C. Pache, N. Howarth Fungal infections in transplant recipients Eur Respir J 17 2001 133
6. J. Briegel, H. Forst, B. Spill Risk factors for systemic fungal infections in liver transplant recipients Eur J Clin Microbiol Infect Dis 14 1995 375
7. R.K. Avery Prophylactic strategies before solid-organ transplantation Curr Opin Infect Dis 17 2004 353
8. R.A. Calderone, W.A. Fonzi Virulence factors of Candida albicans Trends Microbiol 9 2001 327
9. W.L. Chaffin, J.L. Lopez-Ribot, M. Casanova Cell wall and secreted proteins of Candida albicans identification, function and expression Microbiol Mol Biol Rev 62 1998 130
10. R. Tsuboi, H. Komatsuzaki, H. Ogawa Induction of an extracellular esterase from Candida albicans and some of its properties Infect Immun 64 1996 2936
11. A.S. Kantarcioglu, A. Yucel Phospholipase and protease activities in clinical Candida isolates with reference to the sources of strains Mycoses 45 2002 160
12. A. Kurnatowska Activity of hydrolytic enzymes of Candida albicans strains isolated from patients with periodontal and membrane mucosae of oral cavity diseases Mycopathologia 141 1998 105
13. A. Borst, A.C. Fluit High levels of hydrolytic enzymes secreted by Candida albicans isolates involved in respiratory infections J Med Microbiol 52 2003 971
14. M.A. Ghannoum Potential role of phospholipases in virulence and fungal pathogenesis Clin Microbiol Rev 13 2000 122
15. B.J. Kullberg, A.M.L. Oude Lashof Epidemiology of opportunistic infections Eur J Med Res 7 2002 183
16. M.W. Ollert, C. Wende, M. Gorlich Increased expression of Candida albicans secretory proteinase, a putative virulence factor, in isolates from human immunodeficiency virus-positive patients J Clin Microbiol 33 1995 2543
17. I. Polacheck, M. Melamed, H. Bercovier Beta-glucosidase in Candida albicans and its application in yeast identification J Clin Microbiol 25 1987 907
18. J.-L. Reymond, D. Wahler Substrate arrays as enzyme fingerprinting tools ChemBioChem 3 2002 701
19. E. Krajewska-Kulak, W. Niczyporuk Influence of cyclosporine A on the lipolytic and proteolytic activity of yeast-like fungi strains (in vitro) Med Sci Monit 4 1998 693
20. P.J. Kennelly R.K. Murray D.K. Granner P.A. Mayes Enzymes: regulation of activities. Harper's Illustrated Biochemistry 2003 Appleton
21. J.R. Perfect, G.M. Cox Virulence mechanisms for fungi Clin Microbiol Newslett 22 2000 113